Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices
Revance Therapeutics, a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection, announced the signing of a definitive agreement to acquire Hint, Inc., a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform......